Want to see NZ:RUA full AI Analyst Report?
Rua Bioscience Ltd. (RUA) Ratios
Rua Bioscience Ltd. Ratios
NZ:RUA's free cash flow for Q4 2026 was $0.00. For the 2026 fiscal year, NZ:RUA's free cash flow was increased by $1.50M and operating cash flow was $-1.50M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.08 | 1.25 | 3.22 | 7.35 | 2.34 |
| Quick Ratio | 0.88 | 1.03 | 2.91 | 7.33 | 2.30 |
| Cash Ratio | 0.18 | 0.13 | 1.02 | 3.32 | 0.39 |
| Solvency Ratio | -1.01 | -1.62 | -13.69 | -6.35 | -0.83 |
| Operating Cash Flow Ratio | -1.05 | -1.48 | -4.11 | -7.51 | -1.39 |
| Short-Term Operating Cash Flow Coverage | -1.75 | -4.14 | 0.00 | 0.00 | -52.72 |
| Net Current Asset Value | $ 211.68K | $ 414.59K | $ 1.84M | $ 4.77M | $ 2.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.24 | 0.11 | 0.02 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.41 | 0.15 | 0.02 | 0.01 | 0.03 |
| Debt-to-Capital Ratio | 0.29 | 0.13 | 0.02 | 0.01 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.69 | 1.38 | 1.14 | 1.04 | 1.39 |
| Debt Service Coverage Ratio | -1.45 | -3.50 | -788.32 | -275.44 | -45.93 |
| Interest Coverage Ratio | -10.62 | -20.60 | -311.07 | -644.26 | -200.93 |
| Debt to Market Cap | 0.18 | 0.14 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| Net Debt to EBITDA | -0.41 | -0.17 | 0.06 | 0.46 | 0.16 |
| Profitability Margins | |||||
| Gross Profit Margin | -48.84% | 48.60% | -137.83% | 5.07% | -21537.05% |
| EBIT Margin | -130.29% | -171.68% | -15962.67% | -1660.56% | -31306.49% |
| EBITDA Margin | -114.61% | -150.47% | -15496.88% | -1469.05% | -27361.34% |
| Operating Profit Margin | -130.44% | -173.59% | -6115.07% | -3436.57% | -33856.96% |
| Pretax Profit Margin | -130.14% | -181.90% | -15982.33% | -1665.90% | -30900.62% |
| Net Profit Margin | -130.14% | -181.90% | -15982.33% | -1666.12% | -35647.87% |
| Continuous Operations Profit Margin | -130.14% | -181.90% | -15982.33% | -1666.12% | -35647.87% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.01% | 115.36% |
| EBT Per EBIT | 99.77% | 104.79% | 261.36% | 48.48% | 91.27% |
| Return on Assets (ROA) | -46.84% | -51.03% | -177.25% | -28.44% | -25.72% |
| Return on Equity (ROE) | -78.96% | -70.66% | -202.74% | -29.62% | -35.69% |
| Return on Capital Employed (ROCE) | -78.68% | -66.91% | -76.45% | -60.89% | -28.56% |
| Return on Invested Capital (ROIC) | -56.03% | -58.61% | -75.91% | -60.75% | -28.31% |
| Return on Tangible Assets | -67.49% | -75.50% | -247.41% | -58.33% | -47.69% |
| Earnings Yield | -35.71% | -71.43% | -192.63% | -29.75% | -20.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.92 | 5.32 | 0.31 | 0.41 | 0.02 |
| Payables Turnover | 3.87 | 1.14 | 0.49 | 1.23 | 0.41 |
| Inventory Turnover | 6.53 | 2.41 | 0.74 | 23.71 | 0.59 |
| Fixed Asset Turnover | 1.46 | 0.86 | 0.03 | 0.08 | 0.00 |
| Asset Turnover | 0.36 | 0.28 | 0.01 | 0.02 | 0.00 |
| Working Capital Turnover Ratio | 7.49 | 1.59 | 0.03 | 0.06 | 0.00 |
| Cash Conversion Cycle | 35.73 | -99.49 | 922.37 | 598.51 | 15846.15 |
| Days of Sales Outstanding | 74.16 | 68.55 | 1176.21 | 880.66 | 16125.98 |
| Days of Inventory Outstanding | 55.89 | 151.42 | 496.22 | 15.39 | 620.82 |
| Days of Payables Outstanding | 94.33 | 319.46 | 750.06 | 297.55 | 900.64 |
| Operating Cycle | 130.06 | 219.97 | 1672.43 | 896.06 | 16746.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.04 | -0.05 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.04 | -0.05 |
| Dividend Paid and CapEx Coverage Ratio | -1997.02 | -792.72 | -2969.39 | -77.64 | -16.94 |
| Capital Expenditure Coverage Ratio | -1997.02 | -792.72 | -2969.39 | -77.64 | -16.94 |
| Operating Cash Flow Coverage Ratio | -1.72 | -3.70 | -24.33 | -49.99 | -8.22 |
| Operating Cash Flow to Sales Ratio | -1.17 | -1.43 | -41.89 | -16.01 | -279.71 |
| Free Cash Flow Yield | -32.16% | -56.27% | -50.51% | -28.96% | -17.15% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.80 | -1.40 | -0.52 | -3.36 | -4.85 |
| Price-to-Sales (P/S) Ratio | 3.64 | 2.55 | 82.97 | 56.01 | 1727.52 |
| Price-to-Book (P/B) Ratio | 2.21 | 0.99 | 1.05 | 1.00 | 1.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.11 | -1.78 | -1.98 | -3.45 | -5.83 |
| Price-to-Operating Cash Flow Ratio | -3.11 | -1.78 | -1.98 | -3.50 | -6.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | 0.02 | -0.01 | 0.10 | -0.07 |
| Enterprise Value Multiple | -3.59 | -1.87 | -0.48 | -3.35 | -6.15 |
| Enterprise Value | 10.63M | 5.33M | 6.37M | 17.62M | 40.78M |
| EV to EBITDA | -3.59 | -1.87 | -0.48 | -3.35 | -6.15 |
| EV to Sales | 4.12 | 2.81 | 74.26 | 49.26 | 1683.21 |
| EV to Free Cash Flow | -3.51 | -1.96 | -1.77 | -3.04 | -5.68 |
| EV to Operating Cash Flow | -3.52 | -1.96 | -1.77 | -3.08 | -6.02 |
| Tangible Book Value Per Share | 0.01 | 0.02 | 0.02 | 0.06 | 0.06 |
| Shareholders’ Equity Per Share | 0.01 | 0.03 | 0.04 | 0.13 | 0.16 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.00 | -0.15 |
| Revenue Per Share | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.02 | -0.07 | -0.04 | -0.06 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.15 |
| Interest Burden | 1.00 | 1.06 | 1.00 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.33 | 0.50 | 13.70 | 4.44 | 122.91 |
| SG&A to Revenue | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.00 | 0.25 | -5.75 |
| Income Quality | 0.90 | 0.79 | 0.26 | 0.96 | 0.78 |
Currency in NZD